Information  X 
Enter a valid email address

AstraZeneca PLC (AZN)

  Print      Mail a friend       Annual reports

Monday 01 October, 2012

AstraZeneca PLC

AstraZeneca suspends share repurchase programme

RNS Number : 6025N
AstraZeneca PLC
01 October 2012
 



ASTRAZENECA SUSPENDS SHARE REPURCHASE PROGRAMME,

CORE EPS TARGET IN THE RANGE OF $6.00 AND $6.30 UNCHANGED

 

 

 

AstraZeneca today announced that it is suspending share repurchases with immediate effect.  During 2012 the company has completed net share repurchases of $2.3 billion in respect of its initial target of $4.5 billion.

 

AstraZeneca confirms its Core EPS target range for the Full Year 2012 is maintained at $6.00 to $6.30.

 

Pascal Soriot, Chief Executive Officer, AstraZeneca said: "As I assume my new responsibilities at AstraZeneca, I believe this is a prudent step that maintains flexibility while the Board and I complete the company's ongoing annual strategy update." 

 

In line with usual practice, AstraZeneca will update the market on the outlook for 2013 in conjunction with the Full Year 2012 Financial Results announcement in January.

 

About AstraZeneca

AstraZeneca is a global, innovation-driven biopharmaceutical business with a primary focus on the discovery, development and commercialisation of prescription medicines for gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology and infectious disease. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. For more information please visit: www.astrazeneca.com

 

CONTACTS

 

Media Enquiries UK

Esra Erkal-Paler                     +44 207 604 8030

Sarah Lindgreen                     +44 20 7604 8033

 

Media Enquiries Sweden

Ann-Leena Mikiver                   +46 8 553 260 20

 

Investor Enquiries

UK



James Ward-Lilley

Karl Hård

+44 207 604 8122

+44 20 7604 8123

mob: +44 7785 432613

mob: +44 7789 654364

Nicklas Westerholm

US

+44 20 7604 8124

mob: +44 7585 404950

 

 

 

1st October 2012                    

 

-     ENDS  -


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBKDDQDBDDBKK